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ABSTRACT: Some felid diets contain isofl avones 
but the metabolic capacity of cats toward isofl avones 
is relatively unknown, despite the understanding 
that isofl avones have divergent biological potential 
according to their metabolite end products. The 
objective of this study was to determine the plasma 
metabolites detectable in domestic cats after exposure 
to 2 different dietary forms of isofl avones, either as a 
soy extract tablet (n = 6) or as part of a dietary matrix 
(n = 4). Serial blood samples were collected after 
isofl avone exposure to identify the plasma metabolites 
of each cat. Genistein was detected in its unconjugated 
form or as a monosulfate. Daidzein was detected as both 
a mono- and disulfate as well as in its unconjugated 
form. Other daidzein metabolites detected included 
equol mono- and disulfate, dihydrodaidzein, and 
O-desmethylangolensin. No β-glucuronide metabolites 
of either isofl avone were detected. Equol was 
produced in markedly fewer cats after ingestion of a 
soy extract tablet as a single oral bolus compared with 
cats consuming an isofl avone-containing diet. The 
detectable metabolites of the isofl avones, genistein 
and daidzein, in domestic cat plasma after dietary 
ingestion has been described in the present study for 
the fi rst time. The metabolic capacity for isofl avones 
by domestic cats appears to be effi cient, with only 
minimal proportions of the ingested amount detected in 
their unconjugated forms. This has implications for the 
potential of isofl avones to exert physiological activity 
in the domestic cat when consumed at concentrations 
representative of typical dietary intake.
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INTRODUCTION
Isofl avones are nonsteroidal plant compounds 
commonly found in soy and soy products (Kurzer 
and Xu, 1997). In domestic cats (Felis catus), the 
isofl avones genistein and daidzein have elicited 
changes in sex steroid receptor expression (Bell et al., 
2008), innate and acquired immunity, food intake, and 
 at Brackenhurst Library, The Library - Attn:Beth Gibb on June 27, 2013www.journalofanimalscience.orgDownloaded from 
Whitehouse-Tedd et al.1296
lean body mass (Cave et al., 2007b,c,d) whereas diets 
containing soy have also been associated with changes 
in serum thyroid hormone (T4) concentrations (White et 
al., 2004).
Studies have shown that some domestic cat diets 
available in North America and New Zealand contain 
substantial concentrations of genistein and daidzein, 
with up to 249 μg genistein and 151 μg daidzein/g DM 
(Court and Freeman, 2002; Bell et al., 2006b). The 
isofl avone content of felid diets has been assumed to 
result primarily from the inclusion of soy products in the 
formulation of these diets (Setchell et al., 1987; Court 
and Freeman, 2002).
The potential for isofl avones to exert biological 
activity in felids depends initially on the ability of felid 
species to absorb and metabolize these compounds once 
ingested. Genistein and daidzein undergo considerable 
metabolism in the gut wall before entering the portal and 
peripheral circulation (Sfakianos et al., 1997; Prasain et 
al., 2006). Such metabolic modifi cation may infl uence 
isofl avone binding to estrogen receptors or other 
proteins and may be important in explaining the diverse 
array of responses elicited by isofl avones under different 
study conditions (Barnes et al., 2000; Kinjo et al., 2004). 
However, detailed investigation of the manner that feline 
species metabolize dietary isofl avones has not previously 
been undertaken. The current study was designed to 
quantify the isofl avones and their metabolites present in 
the plasma of cats after ingestion of either a single oral 
bolus of soy extract or a commercially available feline 
diet known to contain isofl avones.
MATERIALS AND METHODS
Two experiments were conducted to determine the 
metabolism of genistein and daidzein after 1) ingestion 
of a soy extract and 2) ingestion of a commercially 
prepared feline diet. Studies were approved by Massey 
University’s Animal Ethics Committee (Anonymous, 
2003).
Animals
All cats were born, raised, and housed at Massey 
University’s Center for Feline Nutrition (Palmerston 
North, New Zealand) and had been maintained on a 
commercially prepared, isofl avone-free diet for 4 wk 
before initiation of the studies (washout period estimated 
from a half-life of 22 h for conjugated genistein; Cave 
et al., 2007a). Each cat had been vaccinated against 
feline herpes-1, calicivirus, and panleukopenia using 
a modifi ed live vaccine (Felocell CVR; Norden 
Laboratories, München, Germany). Antibiotics had not 
been administered to any of the cats for at least 3 mo 
before the studies.
For the duration of the studies, cats were individually 
housed in polythene plastic metabolism cages (0.8 by 
0.8 by 1.1 m) equipped with an elevated rest area, feed 
and water bowl area, and a litter tray (Hendriks et al., 
1999). The cats were exposed to natural light cycles, 
provided with ad libitum access to water, and weighed 
weekly without restriction of food or water.
Plasma Analysis
A liquid chromatography (LC) electrospray 
ionization (ESI)-multiple reaction ion monitoring 
(MRM)-tandem mass spectrometry (MS/MS) assay 
was developed to measure simultaneously intact 
isofl avone sulfates and their aglycones in plasma. 
Isofl avone sulfate standards (genistein 4′-monosulfate, 
daidzein 4′-monosulfate, equol 7-monosulfate, equol 
4′-7-disulfate, and daidzein 4′-7-disulfate; N. Botting, 
Dep. of Chemistry, St. Andrew’s University, Fife, 
UK), genistein, daidzein, and equol (LC-Laboratories, 
Woburn, MA), and solvents (Fisher, Norcross, GA) 
were obtained accordingly.
A protein precipitation method was used for 
extraction. Samples were diluted 5-fold with methanol 
containing 0.1% acetic acid (vol/vol), vortexed, and 
centrifuged at 1,800 × g for 10 min at room temperature 
before the supernatant was extracted for the LC–MS/MS 
analysis. The liquid chromatography system consisted 
of a reversed-phase phenyl-hexyl column (100 by 2.0 
mm i.d.; Phenomenex, Torrance, CA). The mobile phase 
consisted of a mixture of solvent A (water, containing 10 
mmol/L ammonium acetate) and solvent B (acetonitrile, 
containing 10 mmol/L ammonium acetate) with a fl ow 
rate of 0.2 mL/min. A 15-min assay was established 
using a linear gradient from 10 to 100% B over the fi rst 
10 min; then the system was returned to the initial 10% 
B at 11 min to allow for equilibration.
Liquid chromatography-MS/MS analysis was 
performed using a system consisting of a refrigerated 
autosampler (Model SIL-HT; Shimadzu Scientifi c 
Instruments, Columbia, MD) and a mass spectrometer 
(API 4000; Applied Biosystems/MDS Sciex, Concord, 
ON, Canada), which was used for quantifi cation and 
identifi cation. Nitrogen was used as the nebulizing gas. 
Liquid chromatography-MS/MS was operated in the 
MRM mode. Mass transitions (mass-to-charge ratio 
[m/z]) used for MRM analysis were 333/117 (daidzein 
4′-monosulfate), 413/333 (daidzein 4′-7-disulfate), 
349/269 (genistein 4′-monosulfate), 401/321 (equol 
4′-7-disulfate), 321/121 (equol monosulfate), 
269/133 (genistein), 253/132 (daidzein), 255/149 
(dihydrodaidzein), 241/119 (equol), and 257/108 
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[O-desmethylangolesin (O-DMA)]. Additional 
transitions were monitored for isofl avone mono-
β-glucuronides, m/z 429/253 (daidzein), 445/269 
(genistein), and 417/241 (equol). Figure 1 illustrates the 
isofl avone structures. The quantifi cation of isofl avone 
sulfates was based on a calibration curve of each 
isofl avone sulfate in the concentration range of 10 to 
10,000 nmol/L. Apigenin (mass transition, m/z 269/149) 
was used as internal standard.
Validation Study
Stock solutions of each analyte were prepared in 
dimethyl sulfoxide, and standard working solutions 
containing chrysin (internal standard, 5 μmol/L) were 
prepared by appropriate dilution in 80% aqueous 
methanol. The analytical method was validated to 
demonstrate the specifi city, lower limit of quantifi cation, 
accuracy, and precision of measurements. Specifi city 
was established by the lack of interference peaks 
at the retention time for the internal standard and 
isofl avone standards. Linearity was tested at 9 levels of 
concentrations, covering a range of 0.01 to 10 μmol/L. 
The calibration curves were established by plotting the 
peak area ratio of the analytes to the internal standard 
(chrysin) compared with analyte concentrations in the 
calibration samples. The regression estimates, slope, 
intercept, and correlation coeffi cient were calculated by 
linear least-square regression (1/x2 weighting).
The accuracy and precision (presented as % CV) of 
this analytical method were determined using quality 
control (QC) samples (n = 3) in 5 to 6 replicates of 0.02, 
0.2, and 2 μmol/L of analytes. For determination of the 
intrabatch accuracy and precision, replicate analysis 
of all analytes was performed on the same day. The 
run consisted of calibration curves and 6 replicates of 
QC samples 0.02 (lower), 0.2 (middle), and 2 μmol/L 
(higher). All these samples were analyzed on 3 different 
batches to determine intrabatch and interbatch accuracy 
and precision. Accuracy was determined by comparing 
the calculated concentration using calibration curves 
with known concentration. The limit of quantifi cation 
(LOQ) was defi ned as precision and accuracy within 
15%. The lower limit of quantifi cation was defi ned 
as the smallest amount of the analyte that could be 
measured in a sample with suffi cient precision and 
accuracy (within 20% for both terms) and was chosen 
as the lowest concentration on the calibration curve. The 
LOQ for dihydrodaidzein and O-DMA was previously 
determined to be 1 to 5 nM (Prasain et al., 2010).
Experiment 1
This study aimed to determine isofl avone metabolites 
present after ingestion of a single oral bolus of soy 
extract. Six adult castrated male, domestic short-haired 
cats with a mean age of 3.75 ± 0.65 yr and an average 
BW of 4.58 ± 0.12 kg were used in this study. Twenty-
four hours before the start of the study, indwelling 
catheters (central venous catheter; Shoof International, 
Cambridge, New Zealand) were placed in a jugular vein 
of each cat according to standard aseptic veterinary 
procedures (Seldinger technique; Seldinger, 1953). 
Food was withheld 18 h before oral administration of 
1 soy extract tablet (approximately 0.218 g, Phytolife1 
One a Day; Healthy Living, Palmerston North, New 
Zealand). Analysis by HPLC (Bell et al., 2006b) showed 
that on average, 1 tablet contained 10.17 mg genistein 
and 13.12 mg daidzein (as-fed) as aglycone equivalents. 
One-half of the daily allowance (293 kJ·kg BW–1·d–1; 
NRC 1986) of an isofl avone-free diet (Table 1) of each 
cat was offered 5 min before administering the tablet. 
The diet was a nutritionally complete and balanced, 
moist commercial diet, which met the maintenance 
nutrient requirements of adult cats (AAFCO, 2009) 
and contained the following ingredients: selected meat 
byproducts and meat derived from beef, lamb, and 
chicken; fi sh byproduct; vegetable protein; gelling 
agents; calcium; coloring; and necessary vitamins. 
This diet was previously analyzed (Bell et al., 2006b), 
and no detectable isofl avones (genistein, daidzein, 
formononetin, and biochanin A) were found.
Blood samples (1.5 mL) were collected via the 
indwelling catheter into sterile, heparinized vacutainers 
(containing 34 IU heparin) at 0, 2, 4, 6, and 12 h after 
isofl avone ingestion. Catheter patency was maintained 
by fl ushing with 1 mL sterile heparinized saline (10 
IU/mL) after each sample collection. Within 10 min of 
Figure 1. Structure of isofl avone metabolites. Top: daidzein disulfate 
[mass-to-charge ratio (m/z): 413/333], middle: daidzein monosulfate (m/z: 
333/117), and bottom: genistein monosulfate (m/z: 349/269).
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collection, the blood was centrifuged at 1,130 × g for 
10 min at room temperature, and plasma was collected, 
transferred to labeled vials, and stored at –20°C until 
analysis. After the fi nal sampling period, the catheters 
were removed, and cats were returned to their normal 
group housing facilities.
Experiment 2
This study aimed to determine isofl avone metabolites 
present after ingestion of an isofl avone-containing, 
commercially prepared diet. Four adult castrated male, 
domestic short-haired cats with a mean age of 4.80 ± 
1.83 yr and BW of 4.55 ± 0.55 kg were gradually 
adapted over a 10-d period before the start of the trial 
to a moist, commercially prepared meat and gravy 
formula diet containing (as aglycone equivalents; Bell 
et al., 2006b) 151 μg genistein and 1,984 μg daidzein/g 
DM (Table 1). During the 10 d, cats were offered an 
amount of food in 2 distinct meals (0900 and 1700 h) 
to meet their maintenance energy requirements (293 
kJ·kg BW–1·d–1; NRC, 1986). The dietary ingredients 
were meat byproducts and meat (including beef), cereal 
byproducts, vegetable protein, gelling agents, calcium, 
starch, coloring, and essential vitamins. The proximate 
composition of the diet is described in Table 1.
Placement of indwelling catheters and blood 
collection were the same as those described in Exp. 1. 
After an 18-h fast, a baseline blood sample was collected 
from the catheter of each cat (time 0), and then each cat 
was given an amount of food equivalent to 50% of their 
individual daily ME requirements. Cats were allowed 
10 min to consume the food, and any remaining food 
was weighed. The time that the meal was consumed 
was recorded, and serial blood samples were taken at 
0.75, 1.5, 2.5, 4, 6, 8, and 12 h after food ingestion. 
After obtaining the fi nal blood sample, the catheter was 
removed and cats were returned their normal group 
housing conditions.
Statistical Analyses
All absorption and excretion variables were 
normalized to the individual dose for each cat before 
averaging. All values are expressed as mean ± SEM unless 
otherwise stated. The maximum plasma concentration 
(Cmax) and time to achieve Cmax (Tmax) were 
determined using noncompartmental modeling software 
(WinNonLin Professional, version 4.1; Pharsight Corp., 
Cary, NC). Noncompartmental methods using the linear 
trapezoidal rule with extrapolation to infi nity was used to 
estimate the area under the curve (AUC0–12) to estimate 
isofl avone metabolite absorption over the 12-h sampling 
period. Curves were plotted for each cat before average 
Tmax and Cmax values were calculated.
RESULTS
Liquid Chromatography-Tandem Mass Spectrometry 
Analysis of Plasma Isofl avones
The calibration curves for the isofl avone standards 
were generated at different concentrations ranging 
from 0.01 to 10 μmol/L. The standard curve was linear 
over this 1,000-fold concentration range. The MRM 
chromatograms of genistein, daidzein, and equol and 
their sulfate conjugate standards are shown in Fig. 2. The 
assay method for quantifi cation of plasma isofl avone 
metabolites was demonstrated to be very sensitive and 
specifi c, and a linear response was obtained over a range 
of 0.01 to 10 μmol/L with a correlation coeffi cient of 
0.99. The LOQ was 0.01 μmol/L.
The accuracy and precision of this assay for 
isofl avone sulfates and aglycones were determined 
at various concentrations (0.02, 0.2, and 2 μmol/L) 
using QC samples, and the within-assay accuracies 
and precisions for analytes were in the range of 84 
to 121% and 3 to 17%, respectively. For the lowest 
quality control (0.02 μmol/L), the interbatch (between 
assay) precisions for the analytes were less than 14%, 
and the accuracies were between 91 and 103%. The 
method was sensitive, reproducible, and reliable, and 
the LOQ was 0.02 μmol/L.
Experiment 1
Cats ingested an average of 2.22 ± 0.06 mg genistein 
and 2.86 ± 0.08 mg daidzein/kg BW. Unconjugated 
daidzein and genistein were detected in the plasma 
of 5 of the 6 cats. No β-glucuronide metabolites were 
detected in any of the plasma samples. The metabolites, 
daidzein monosulfate, daidzein disulfate, and genistein 
monosulfate, were detected in the plasma of all cats 
(Fig. 3). Both unconjugated genistein and daidzein 
Table 1. Proximate composition of diets
Component Exp. 1 Exp. 2
DM, % as is 17.7 15.5
CF, % DM 25.2 23.3
CP, % DM 35.7 47.0
CHO,1 % DM 29.2 20.0
Ash, % DM 6.90 7.68
ME,2 kJ/g DM 18.9 18.4
Genistein, μg/g DM 0.00 151
Daidzein, μg/g DM 0.00 198
1Carbohydrate calculated by difference (100 – CP – crude fat – ash).
2Calculated using modifi ed Atwater factors (CP × 3.5, crude fat × 8.5, and 
carbohydrate × 3.5).
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were no longer detectable in plasma at 12 h after 
isofl avone ingestion although all other metabolites 
were still detectable at this fi nal sampling point. Equol 
(monosulfate) was only detected at the fi nal sampling 
point (12 h after dose) in 1 cat (Fig. 3). No other forms 
of equol were detected in any of the plasma samples. 
Dihydrodaidzein and O-DMA were not detected in 
any of the plasma samples. Plasma appearance and 
disposition curves for the 3 major metabolites are shown 
in Fig. 4.
Unconjugated genistein and daidzein exhibited the 
earliest Tmax whereas daidzein disulfate was the last to 
reach its maximum concentration. The greatest Cmax was 
achieved by genistein monosulfate, and unconjugated 
genistein and daidzein exhibited the least Cmax. The 
Cmax and Tmax of detected metabolites are shown in 
Table 2.
The proportion of administered genistein recovered 
in the plasma as a sulfate conjugate (estimated from 
the AUC0–12h), was similar at all sampling points (i.e., 
mean 99.41 ± 0.00% at 2 h and 99.98 ± 0.00% at 12 h). 
Likewise, the proportion of administered daidzein 
recovered in the plasma as a sulfate conjugate was 
99.03 ± 0.00% on average at 2 h and 99.93 ± 0.00% at 
12 h. No difference was detectable between the extent of 
conjugation for genistein or daidzein.
Experiment 2
Cats consumed an average of 0.62 ± 0.06 mg 
genistein and 0.82 ± 0.08 mg daidzein/kg BW, providing 
a total mean isofl avone dose of 1.44 mg/kg BW. Three 
of the 4 cats consumed less (by an average of 21.1%) 
than that predicted from their average intake per meal 
from the previous 5 d whereas 1 cat consumed slightly 
more than anticipated (15.7%).
Daidzein monosulfate, genistein monosulfate, and 
equol monosulfate were present in the plasma of all cats 
(Table 3; Fig. 5). Daidzein disulfate and equol disulfate 
were detected in 3 of 4 cats. The disulfate metabolites 
of daidzein and equol and the monsulfate of genistein 
were present in the baseline plasma sample of cats. 
Unconjugated equol was not detected in the plasma of 
any cat. Dihydrodaidzein and O-DMA were detected in 
1 cat. No β-glucuronide metabolites were detected in 
any cat. The Tmax and Cmax of isofl avone metabolites 
are shown in Table 3.
Plasma appearance and disposition curves for the 3 
major metabolites are shown in Fig. 6. One cat (number 
10) appeared divergent in its plasma metabolite profi le 
(qualitatively and quantitatively), and as such, its plasma 
data are reported separately (Table 3). This cat was the 
only cat observed to have detectable concentrations 
of unconjugated genistein and daidzein and had 
simultaneously less than average concentrations of the 
monosulfate conjugates of these isofl avones. Likewise, 
this cat did not produce any disulfate metabolite whereas 
the other 3 cats did. Equol monosulfate was detected 
in concentrations (0.16 μmol/L at only 1 time point) 
less than observed in other cats (mean, 1.43 ± 0.71 
μmol/L). This cat produced detectable concentrations 
of dihydrodaidzein and O-DMA whereas the other 3 
cats did not. Excluding the apparent outlier (cat number 
10), genistein and daidzein monosulfate exhibited the 
Figure 2. Multiple reaction ion monitoring chromatograms of genistein, daidzein, and equol and their sulfate conjugate standards. Mass transitions used 
were mass-to-charge ratio (m/z): 333/117 (daidzein 4′-monosulfate), 413/333 (daidzein 4′,7-disulfate), 349/269 (genistein 4′-monosulfate), 401/321 (equol 
4′,7-disulfate), 321/121 (equol monosulfate), 269/133 (genistein), 253/132 (daidzein), and 241/119 (equol). MRM = multiple reaction ion monitoring; cps = 
counts per second.
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earliest Tmax, and equol disulfate was the last to reach 
its maximum concentration. Genistein monosulfate 
achieved the greatest Cmax whereas the lowest Cmax was 
observed for equol disulfate.
The amount of administered genistein recovered in 
the plasma as a sulfoconjugate did not vary according to 
sampling time, ranging from 99.60 ± 0.00% at 1.5 h up 
to 100.00 ± 0.00% at 6 and 12 h after dose. The amount 
of administered daidzein recovered in the plasma as a 
sulfate conjugate also did not vary, ranging from 99.60 
± 0.00% at 1.5 h after dose to 100.00 ± 0.00% at 4, 6, 
and 12 h after dose.
Comparison of Experiment 1 and Experiment 2
Table 4 presents the incidence of detecting each 
isofl avone metabolite at any time point in plasma of 
Figure 3. Individual multiple reaction ion-monitoring channels for plasma isofl avone sulfate conjugates from a cat fed a soy extract tablet bolus. (A) Daidzein 
monosulfate, (B) daidzein disulfate, (C) genistein monosulfate, (D) equol monosulfate, and (E) equol disulfate. There were no peaks that corresponded to the stan-
dards (0.1 M solution) for (D) and (E) as illustrated in (F). The concentrations (μmol/L) of each isofl avone sulfate are given on the left side of each peak. cps = counts 
per second; m/z = mass-to-charge ratio.
Figure 4. Mean plasma concentration of 3 major metabolites identifi ed 
in domestic cats (n = 6) after exposure to soy extract tablets containing 10.17 
mg genistein and 13.12 mg daidzein (as-fed) providing 2.22 mg genistein and 
2.86 mg daidzein/kg BW. 
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cats ingesting the soy extract tablet (Exp. 1) and the cats 
consuming an isofl avone-containing diet (Exp. 2). The 
incidence of unconjugated genistein and daidzein were 
both greater in Exp. 1 than Exp. 2 whereas the incidence 
of mono- or disulfates of either of these isofl avones 
was similar between experiments. Equol mono- and 
disulfates as well as dihydrodaidzein and O-DMA were 
only detected in Exp. 2. The proportion of total genistein 
or daidzein metabolites detected at 12 h as a conjugated 
form was similar between dietary forms.
DISCUSSION
A key element in the present study was the 
development of a rapid and sensitive LC-ESI-MS/MS 
assay to simultaneously quantify isofl avone aglycones 
and sulfates in plasma to enable the identifi cation and 
quantifi cation of isofl avone metabolites in domestic cat 
plasma. The methods developed in the present study will 
be of value in supporting future pharmacokinetic studies 
in cats. We optimized chromatographic conditions to 
provide shorter retention times, adequate peak shape as a 
modifi cation of the LC-MS/MS method for quantifi cation 
of intact sulfate, and glucuronide isofl avones in human 
urine reported by Clarke et al. (2002).
The fi rst indication that dietary isofl avones may be 
absorbed by a felid species was provided by Setchell 
et al. (1987). Cheetahs (Acinonyx jubatus) consuming 
a diet containing soy protein produced urine with a 
number of unidentifi ed phenol-like compounds in the 
unconjugated steroid fraction (Setchell et al., 1987). 
These compounds were thought to represent metabolites 
of genistein and daidzein, which were found in the 
diet (Setchell et al., 1987), but the urinary compounds 
were not positively identifi ed. Likewise, Brown et al. 
(1994) provided indirect evidence that domestic cats 
may be capable of converting daidzein into a more 
biologically potent form, equol, through their incidental 
fi nding of this metabolite in domestic cat feces. More 
recently, quantifi cation of the relative proportions of 
unconjugated and conjugated genistein in cat plasma 
showed that, contrary to previous hypotheses, cats do 
indeed have capacity for the conjugation of genistein 
although the specifi c metabolites were not identifi ed 
(Bell et al., 2006a; Cave et al., 2007a).
In agreement with the fi ndings of Cave et al. (2007a), 
both genistein and daidzein appeared in detectable 
concentrations in the plasma of adult domestic cats 
after ingestion of an isofl avone-containing tablet. 
Furthermore, the current study has also confi rmed the 
ability of dietary isofl avones to cross the intestinal 
barrier of the cat when ingested as part of a commercially 
available feline diet.
Table 2. Mean plasma appearance variables in adult cats 
(n = 6) administered with 2.22 mg genistein and 2.86 mg 
daidzein/kg BW via a soy extract tablet1,2
Metabolite Tmax, h Cmax, μmol/L
Unconjugated genistein 2.40 ± 0.09 0.09 ± 0.04
Unconjugated daidzein 2.40 ± 0.69 0.10 ± 0.10
Genistein monosulfate 3.00 ± 0.68 14.43 ± 4.02
Daidzein monosulfate 4.33 ± 1.58 6.66 ± 1.67
Daidzein disulfate 4.67 ± 1.52 3.27 ± 0.73
1Phytolife1 One a Day (Healthy Living, Palmerston North, New Zealand).
2Cmax = the maximum plasma concentration; Tmax = time to achieving Cmax.
Table 3. Mean plasma appearance variables in cats (n = 
3) and 1 outlier cat fed a diet containing 151 μg genis-
tein and 198 μg daidzein/g DM1,2
Metabolite
Tmax, h Cmax, μmol/L
Mean, n = 3 n = 1 Mean, n = 3 n = 1
Unconjugated genistein ND3 1.50 ND 0.26
Unconjugated daidzein ND 4.00 ND 0.19
Genistein monosulfate 1.83 ± 0.29 1.50 1.78 ± 0.33 0.19
Daidzein monosulfate 1.83 ± 0.29 1.50 1.33 ± 0.28 0.05
Daidzein disulfate 2.50 ± 0 ND 1.46 ± 0.16 ND3
Equol monosulfate 7.00 ± 1.15 ND 1.43 ± 0.71 ND3
Equol disulfate 8.25 ± 3.75 ND 0.64 ± 0.20 ND3
1Average intake of isofl avones was 0.62 mg genistein and 0.82 mg 
daidzein/kg BW.
2Cmax = the maximum plasma concentration; Tmax = time to achieving Cmax.
3ND = not detected.
Table 4. Comparative incidence of the detection of 
isofl avone metabolites in the plasma of cats fed either a 
soy extract tablet (Exp. 1) or a diet containing isofl avones 
(Exp. 2)1
Metabolite
Exp. 1 (soy 
extract, n = 6)
Exp. 2 (dietary 
matrix, n = 4)
Unconjugated genistein 83.3 252
Unconjugated daidzein 83.3 252
Glucuronide from genistein or daidzein 0 0
Genistein monosulfate 100 100
Genistein disulfate 0 0
Daidzein monosulfate 100 100
Daidzein disulfate 100 75
Unconjugated equol 0 0
Equol monosulfate 0 100
Equol disulfate 0 75
Dihydrodaidzein 0 252
O-desmethylangolensin 0 252
Mean proportion of plasma genistein 
metabolites conjugated at 12 h
99.9 100
Mean proportion of plasma daidzein 
metabolites conjugated at 12 h
99.9 100
1Values are expressed as the percentage of cats detected with each 
metabolite present in their plasma at 1 or more time points where the number 
detected vs. the total number of cats is shown in parentheses.
2One cat exhibited a divergent metabolite profi le to other cats in Exp. 2; 
therefore, these results should be interpreted with caution.
 at Brackenhurst Library, The Library - Attn:Beth Gibb on June 27, 2013www.journalofanimalscience.orgDownloaded from 
Whitehouse-Tedd et al.1302
After hydrolysis in the gastrointestinal tract 
and deconjugation of dietary isofl avone glycosides, 
isofl avones are absorbed in their unconjugated 
state (Setchell et al., 2002). In humans and rodents, 
isofl avone metabolism typically involves conjugation 
(Coldham et al., 1999; Setchell, 2000). This phase II 
type of metabolism has been shown to occur in both 
the enterocyte and hepatocyte, with β-glucuronides 
being the predominant conjugate species (Setchell, 
2000). However, isofl avone sulfates are also formed 
in male rats (Coldham et al., 1999). In common with 
humans and rodents (Joannou et al., 1995; Cimino et al., 
1999; Heinonen et al., 1999), the daidzein metabolites, 
dihydrodaidzein, equol, and O-DMA, were detected in 
feline plasma along with sulfoconjugates, unconjugated 
genistein, and daidzein. The presence of other potential 
isofl avone metabolites, such as dihydrogenistein, 
6′-hydroxy-O-DMA, 4-hydroxyphenyl-2-propionic 
acid, p-ethyl-phenol, tetrahydrodaidzein, 4-OH-equol, 
and 2-dehydro-O-DMA, was not investigated.
The lack of detectable β-glucuronide conjugates 
in the plasma of domestic cats in the present 2 
experiments is in agreement with previous fi ndings of a 
poor glucuronidation capacity (Robinson and Williams, 
1958). Indeed, conjugation to form β-glucuronides is 
known to be nonfunctional in the cat against a large 
number of substrates, including phenols (Capel et al., 
1972, 1974; Court and Greenblatt, 2000). However, 
before the current study, no information was available 
regarding the glucuronidation activity toward isofl avones 
in the cat. Hence, a number of authors (Setchell et al., 
1987; Court and Freeman, 2002) have speculated that 
the reduced capacity of cats to form β-glucuronides 
may render them unable to conjugate isofl avones. 
This, in turn, has been hypothesized to translate into a 
greater susceptibility of felids to the biological effects 
Figure 5. Individual multiple reaction ion-monitoring channels for plasma isofl avone sulfate conjugates in a cat fed a commercial isofl avone-containing 
feline diet. (A) Daidzein monosulfate, (B) daidzein disulfate, (C) genistein monosulfate, (D) equol monosulfate, and (E) equol disulfate. The concentrations 
(μmol/L) of each isofl avone sulfate is given on the left side of each peak. cps = counts per second.
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of isofl avones because the unconjugated forms are 
considered to have greater biological potency (Kinjo et 
al., 2004). Furthermore, the excretion or enterohepatic 
recirculation of isofl avones, or both, may depend, to 
some extent, on the manner in which isofl avones are 
metabolized (Sfakianos et al., 1997).
However, the fi ndings of this study provide the fi rst 
evidence that domestic cats are capable of considerable 
metabolism of ingested isofl avones. Indeed, the bulk of 
the detected isofl avones in feline plasma were present 
as conjugates, with only minimal proportions found 
in an unconjugated form. Over 99% of the isofl avones 
detected were conjugated at all time points, indicating 
that the conjugation process is suffi cient to keep up 
with the rate of absorption achieved in the present 
study. Hence, assuming that absorption rate in cats is 
similar to that of other species, felids appear to have 
a conjugation capacity comparable to other species, at 
least when exposed to an acute dose of isofl avones. It 
can, therefore, be expected that cats have a susceptibility 
similar to the physiological changes observed after 
acute isofl avone exposure in other species although 
the metabolic capacity after chronic exposure was not 
investigated and no changes in physiological variables 
were investigated in the current study.
The metabolite profi le of feline plasma reported 
in the present study indicates that phase II metabolism 
of genistein and daidzein involves conjugation with 
only sulfate rather than the typically glucuronide-
dominant pathways observed in other species. The 
family of enzymes responsible for uridine diphosphate-
glucuronosyltransferase (UGT) activity is nonetheless 
expressed in the cat liver (Court and Greenblatt, 1997, 
2000). However, the range of isoforms is considerably 
limited, and UGT activity is considerably less in the cat 
than other mammalian species (Hietanen and Vainoo, 
1973; Court and Greenblatt, 1997, 2000). Our fi ndings 
support the notion that isofl avones are conjugated to a 
sulfate moiety and subsequently excreted in this form.
Sulfotransferases (SULT) are ubiquitous in 
mammalian cells but highly concentrated in the 
liver where they are responsible for conjugation of 
hydrophobic molecules (Shangari et al., 2005). In other 
species, it is thought that SULT work in a complementary 
manner with UGT, providing an effi cient “back-up” for 
conjugating molecules when glucuronidating enzyme 
activity is reduced or saturated (Goon and Klaasson, 
1990; Shangari et al., 2005). Dose–response differences 
in metabolite profi les were not investigated but may be 
of interest for future research.
Sulfation is generally more easily saturated than 
glucuronidation (Goon and Klaasson, 1990), and 
increased isofl avone intake by cats may result in 
disproportionately increased unconjugated isofl avones, 
which has implications for the potential biological activity 
of these compounds in the cat. Furthermore, unlike other 
species, in which glucuronidation and sulfation would 
both need to be impaired, changes in sulfation capacity 
(e.g., via polymorphisms or dysfunctional metabolism) 
in individual cats is likely to infer greater physiological 
consequence than would be predicted in other species.
Some differences in metabolite profi les were 
observed after ingestion of 2 divergent forms of 
isofl avones. In general, the effi ciency of isofl avone 
conjugation was nearly identical in Exp. 1 and 2 when 
the proportion of conjugated metabolites at the 12 h 
sampling point was compared. However, a much greater 
number of cats ingesting soy extract were shown to have 
detectable concentrations of unconjugated genistein 
and daidzein at any time point compared with cats 
consuming an isofl avone-containing diet. This indicates 
that there may be differences in bioavailability or 
enzyme adaptation, or both, depending on the type of 
isofl avone ingested, or the duration of exposure.
Alternatively, provision of isofl avones as a soy 
extract tablet may have resulted in a more rapid absorption 
(which was not detectable within our sampling regimen) 
of isofl avones, thus resulting in an earlier saturation of 
conjugating pathways. However, the absolute values 
reported after soy extract supplementation should 
be interpreted with caution because mixing of the 
tablet may not have been complete, and variation in 
esophageal transit of the tablets may have resulted in the 
isofl avones entering the stomach or intestines before the 
bulk of the meal. However, variable esophageal transit is 
unlikely to have had an effect, and the limited sampling 
regime was not appropriate for the estimation of true 
pharmacokinetic variables or bioavailability.
Given the restricted sampling regime, differences in 
dose received via tablet and dietary administration, and 
the detection of metabolites close to the detection limit 
Figure 6. Mean plasma concentration of 3 major metabolites identifi ed 
in domestic cats (n = 4) after exposure to a commercially prepared feline diet 
containing 151 μg genistein and 198 μg daidzein/g DM. Average intake was 
0.62 mg genistein and 0.82 mg daidzein/kg BW. 
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of the assay, the observed differences between Exp. 1 
and Exp. 2 should be interpreted with caution. Studies 
with extended and more frequent sampling regimens 
to enable comparison of concentrations rather than 
presence or absence are warranted.
A crucial role for intestinal microbiota has previously 
been demonstrated for the production of equol and 
O-DMA (Atkinson et al., 2005; Cassidy, 2005), and equol 
is thought to be produced in the distal intestine, most 
likely the colon (Setchell et al., 2003). The production of 
equol was only apparent in cats consuming isofl avones 
as part of a dietary matrix whereas this metabolite was 
not detected in cats exposed to soy extract tablets. Equol 
is known to possess greater affi nity for estrogen receptor 
binding compared with daidzein in other species 
(Sathyamoorthy and Wang, 1997; Lehmann et al., 
2005). Equol may, therefore, subsequently exert greater 
physiological infl uence than daidzein, so the fi nding that 
all cats (4) exposed to a daidzein-containing diet were 
capable of producing equol may have ramifi cations 
for the long-term reproductive physiology of domestic 
cats fed diets containing daidzein. However, there is a 
discordance between the estrogenic effects of equol in 
vitro or cell culture vs. its lack of estrogenic effect in 
vivo on the growth of human estrogen receptor-positive 
Michigan Cancer Foundation – 7 (MCF-7) cells in the 
ovariectomized nude mouse model (Ju et al., 2006). In 
this mouse model, expected extensive β-glucuronidation 
of equol may have substantially attenuated its estrogenic 
effects in vivo. It remains to be determined in felids 
whether sulfoconjugates of isofl avones and their 
metabolites retain estrogenic activity.
The 12-h sampling period used here was predicted 
to provide suffi cient time for the detection of equol, 
but none of the 6 cats ingesting soy extract exhibited 
detectable concentrations of equol within this sampling 
regimen. This is in contrast to the 100% of cats (4 out 
of 4) consuming the isofl avone-containing diet that 
produced detectable equol by 12 h. Because equol 
was present in baseline samples from noncoprophagic 
cats adapted to an isofl avone-containing diet, some 
unforeseen overlap in plasma isofl avone content from 
previous meals is thought to have occurred, despite the 
18-h food-withholding period before the trial.
It has been suggested that chronic exposure to 
daidzein may increase the equol-producing capacity 
of the gut microbiota of mammals (Hedlund et al., 
2005). Certain gastrointestinal bacteria are known to be 
stimulated by exposure to isofl avones (De Boever et al., 
2000; Clavel et al., 2005), such that prolonged intake 
has been associated with altered isofl avone metabolism 
or absorption, or both, compared with single bolus doses 
(Lu and Anderson, 1998; Hedlund et al., 2005). Hence, 
it is feasible that equol production was increased in Exp. 
2 because of the adaptation period, in which the cats 
consumed the isofl avone diet before sampling. This is 
supported by the fi nding that equol was detectable in 
the baseline sample of the majority of cats in this study. 
Likewise, overlap from previously ingested meals may 
explain the earlier peak plasma concentrations observed 
in the present study (at approximately 8 h) compared with 
studies in humans, in which equol Tmax was typically 
reported to occur after 24 h (Setchell et al., 2003).
Nonetheless, the fi nding that the greatest 
concentration of equol sulfates were detected at 8 h 
after ingestion of the study meal provides evidence 
that equol production was increased as a result of the 
study meal. This indicates some form of modulatory 
role for either the dietary matrix or the duration of 
daidzein exposure in the equol-producing capacity 
of domestic cats. However, it must be noted that the 
sampling regimen used in the present study was not 
suffi cient to accurately predict the true Tmax and further 
investigation of the pharmacokinetics of isofl avones in 
cats is warranted.
Interestingly, 1 cat in Exp. 2 failed to produce 
detectable concentrations of daidzein disulfate or equol 
disulfate, but this cat was also the only cat observed 
to have circulating concentrations of unconjugated 
daidzein. Moreover, this cat was unique in its production 
of dihydrodaidzein and O-DMA, indicating that daidzein 
metabolism differed in this individual compared with 
other cats. It is possible that the presence of daidzein 
or equol disulfate metabolites in this cat occurred in 
periods that were not sampled in this study because of 
the restricted sampling regime. However, the presence 
of these metabolites at sampled time points in all other 
cats in Exp. 2, combined with the unusual metabolite 
profi le of this cat, indicates that study design alone 
cannot explain this fi nding.
A divergent activity of phase II metabolizing 
processes may be exhibited in this individual and may be 
associated with the ability to produce dihydrodaidzein 
and O-DMA. No known variables with the potential to 
alter gut microbiota in this cat were apparent (e.g., no 
antibiotics had been administered and coprophagia was 
not observed or suspected). However, this cat had the 
greatest intake per kilogram BW, which may indicate a 
degree of saturation in the phase II metabolizing process 
that was occurring and could explain the increased 
presence of unconjugated isofl avones.
In humans, only 30% of subjects challenged with 
soy isofl avones are equol producers, which has been 
attributed to the presence of specifi c gut microorganisms 
in individuals (Setchell et al., 2003), such that the 
microbiota of this cat may have differed to others in 
the study. Alternatively, the presence of a SNP in the 
SULT of this cat cannot be ruled out. In humans, these 
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SNP confer functional consequences on the translated 
proteins (Nowell and Falany, 2006), which may explain 
the observed metabolic profi le in this individual although 
the confi rmation of this was beyond the scope of this 
study.
In summary, the identifi cation of isofl avone 
metabolites in the plasma of domestic cats supplemented 
with soy isofl avone or fed a diet containing isofl avones 
from soy may have been described for the fi rst time. The 
potential for conversion of daidzein to equol has also 
been demonstrated in this species, and an infl uence of 
dietary matrix or exposure duration in the production of 
this metabolite may be indicated. Cats have an adequate 
capacity to metabolize isofl avones to sulfate conjugates, 
which is in contrast to previous hypotheses (Setchell 
et al., 1987; Court and Freeman, 2002). Furthermore, 
the metabolic capacity for isofl avone detoxifi cation 
by domestic cats appears to be effi cient, with only 
minimal proportions of the circulating isofl avones 
detected in their unconjugated forms. Unlike all other 
species studied to date, cats do not appear to conjugate 
isofl avones to glucuronide moieties, relying solely 
on sulfation instead. These fi ndings have implications 
for the potential for isofl avones to exert physiological 
activity in the cat. It is unlikely that cats are rendered 
more susceptible to isofl avone biological activity than 
other mammals because of their metabolic differences.
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